6640--CTX Immunoassay Random Access Multiplex Analyzer
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The Department of Veterans Affairs (VA), Network Contracting Office (NCO) 17, is soliciting proposals for a commercial, fully automated, random access multiplex immunoassay analyzer system for the Central Texas Veterans Health Care System (CTVHCS) in Temple, Texas. This acquisition aims to replace an existing end-of-life analyzer. The procurement is UNRESTRICTED and will result in a single firm-fixed-price contract. Offers are due February 13, 2026, at 10:00 AM CST.
Scope of Work
The required system must be a commercial, fully automated, random access multiplex immunoassay analyzer capable of performing autoimmune, infectious disease, and specialty immunoassay testing on a consolidated platform. Key requirements include:
- FDA approved.
- Capable of testing for total Syphilis (IgG and IgM), RPR, and Anti-Nuclear Antibody (ANA).
- Programmable STAT/priority testing.
- Acceptance of CLSI standard specimen tubes.
- Operation on standard 110-volt power with an appropriate uninterruptible power supply (UPS).
- Integrated quality control capabilities.
- Delivery, installation, initial operational verification, and removal of the existing analyzer.
- Operator training, manuals, and maintenance instructions.
Contract & Timeline
- Contract Type: Firm-Fixed-Price
- Acquisition Procedures: FAR Part 12 (Commercial Products and Services) and FAR Part 15.
- NAICS Code: 334516 (Analytical Laboratory Instrument Manufacturing)
- Small Business Size Standard: 1,000 employees
- Questions Due: February 9, 2026, 10:00 AM CST
- Offer Due Date: February 13, 2026, 10:00 AM CST
- Offer Validity: At least 60 calendar days from receipt of offers.
Evaluation
Award will be made using a Lowest Price Technically Acceptable (LPTA) best value approach. Technical acceptability will be evaluated on a pass/fail basis against clearly defined minimum requirements. Among technically acceptable offers, award is expected to be made to the responsible offeror with the lowest total evaluated price, subject to price reasonableness. The evaluation includes an SDVOSB/VOSB factor and tiebreaker.
Eligibility & Submission
This procurement is UNRESTRICTED; all responsible sources may submit an offer. Offerors must be registered in the System for Award Management (SAM) under the applicable NAICS code prior to award. Offers must be submitted electronically via email to the Contracting Officer/Contract Specialist. The email subject line must be: "Offer – Immunoassay Random-Access Multiplex Analyzer [Offeror Name]."
Additional Notes
The solicitation and any amendments will be issued electronically via SAM.gov. Interested parties are responsible for monitoring SAM.gov for updates. The place of performance is the Department of Veterans Affairs, Central Texas Veterans Health Care System, Laboratory, Temple, TX.